ESSA Pharma Inc.

TickerCurrent Price% Daily ChangeVolume (1,000s)Average Volumn (1,000s)Market Cap (Millions)1/2/2024 Price% Change Since Inception 1/2/2024
EPIX$4.986.867%9563$221$6.45-22.8%

Contact Information

ESSA Pharma Inc.
999 West Broadway
Suite 720
Vancouver, BC V5Z 1K5
Canada

ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. ESSA’s lead clinical candidate, EPI-7386, represents a new approach to disrupting androgen receptor signaling pathway, the primary driver of prostate cancer growth.